A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL)-Reference-Cited by-同舟云学术

A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL)

Published:2022-06-21 Issue:7 Volume:6 Page:e745
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Salles Gilles,Schuster Stephen J.,Fischer Luca,Kuruvilla John,Patten Piers E. M.,von Tresckow Bastian,Smith Sonali,Jiménez-Ubieto Ana,Davis Keith L.,Nagar Saurabh,Zhang Jie,Bollu Vamsi,Jousseaume Etienne,Ramos Roberto,Wang Yucai,Link Brian K.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference17 articles.

1. Follicular lymphoma: recent and emerging therapies, treatment strategies, and remaining unmet needs.;Matasar;Oncologist,2019

2. Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the gela-goelams fl2000 study.;Salles;Blood,2008

3. Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma.;Marcus;J Clin Oncol,2008

4. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the german low-grade lymphoma study group.;Hiddemann;Blood,2005

5. Survival after progression in patients with follicular lymphoma: analysis of prognostic factors.;Montoto;Ann Oncol,2002

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization of Real-World Data to Facilitate Clinical Trials for Patients with Lymphoma;Pharmacoepidemiology;2024-08-06

2. Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study;The Lancet Haematology;2024-08

3. Diffuse large B-cell lymphoma and follicular lymphoma: problem state in Russia;Journal of Modern Oncology;2024-07-03

4. A Comparison of 3-Year Follow-up of ZUMA-5 (Axicabtagene Ciloleucel) With SCHOLAR-5 in Relapsed/Refractory Follicular Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2024-05

5. Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update;Blood;2024-04-25